HuffPost: Wonder Woman: Tracy Ryan Makes New Strides With CannaKids

Clients CURE Pharmaceutical and CannaKids featured in Huffington Post article about their newest research project on cannabinoids as a treatment for cancer.

Non-profit does not mean no revenue, it just means all the money gets spent. CannaKids was founded in 2015, but Tracy Terrific has been growing as a social media star since her fight to save Sophie began in 2013. CannaKids has treated over 500 patients with “Western medicine” and “anecdotal cannabinoid dosing” in news released in the same week as the premier of Wonder Woman.

On March 6th, 2017, a press release announced CURE’s collaboration with CannaKids. Cure Pharmaceuticals was trading at $2.90 after its IPO in January. On March 13th, CURE shares reached a high of $15.00 on volume ten times its average daily volume since. The CannaKids press release preceded a $100,000,000 credit to the accounts of the 102 CURE shareholders of record. CURE shares have traded in a range between $5 and $8 and closed trading Friday, June 2 at $7.90.